The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Emergent high fatality lung disease in systemic juvenile arthritis
Open accessAbstract
Objective To investigate the characteristics and risk factors of a novel parenchymal lung disease (LD), increasingly detected in systemic juvenile idiopathic arthritis (sJIA). Methods In a multicentre retrospective study, 61 cases were investigated using physician-reported clinical information and centralised analyses of radiological, pathological and genetic data. Results LD was associated with distinctive features, including acute erythematous clubbing and a high frequency of anaphylactic reactions to the interleukin (IL)-6 inhibitor, tocilizumab. Serum ferritin elevation and/or significant lymphopaenia preceded LD detection. The most prevalent chest CT pattern was septal thickening, involving the periphery of multiple lobes ± ground-glass opacities. The predominant pathology (23 of 36) was pulmonary alveolar proteinosis and/or endogenous lipoid pneumonia (PAP/ELP), with atypical features including regional involvement and concomitant vascular changes. Apparent severe delayed drug hypersensitivity occurred in some cases. The 5-year survival was 42%. Whole exome sequencing (20 of 61) did not identify a novel monogenic defect or likely causal PAP-related or macrophage activation syndrome (MAS)-related mutations. Trisomy 21 and young sJIA onset increased LD risk. Exposure to IL-1 and IL-6 inhibitors (46 of 61) was associated with multiple LD features. By several indicators, severity of sJIA was comparable in drug-exposed subjects and published sJIA cohorts. MAS at sJIA onset was increased in the drug-exposed, but was not associated with LD features. Conclusions A rare, life-threatening lung disease in sJIA is defined by a constellation of unusual clinical characteristics. The pathology, a PAP/ELP variant, suggests macrophage dysfunction. Inhibitor exposure may promote LD, independent of sJIA severity, in a small subset of treated patients. Treatment/prevention strategies are needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans
The GTEx Consortium, Ardlie, K. G., Deluca, D. S., Segrè, A. V., Sullivan, T. J., Young, T. R., Gelfand, E. T., Trowbridge, C. A., Maller, J. B., Tukiainen, T., et al. (2015) · Science · doi:10.1126/science.1262110 · Cited by 5,062
Self-citationInfections and immunodeficiency in Down syndrome
Ram, G., & Chinen, J. (2011) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2011.04335.x · Cited by 465
Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation
Sullivan, K. D., Evans, D., Pandey, A., Hraha, T. H., Smith, K. P., Markham, N., Rachubinski, A. L., Wolter-Warmerdam, K., Hickey, F., Espinosa, J. M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13858-3 · Cited by 228 · cited 1×
“64 An association of T21 and PAP in the context of haematological malignancy also has been reported.”
Kaufman, K. M., Linghu, B., Szustakowski, J. D., Husami, A., Yang, F., Zhang, K., Filipovich, A. H., Fall, N., Harley, J. B., Nirmala, N. R., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38793 · Cited by 207
Self-citation
Cited by
Hemophagocytic lymphohistiocytosis: An update on pathogenesis, diagnosis, and therapy
Griffin, G., Shenoi, S., & Hughes, G. C. (2020) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2020.101515 · Cited by 349
Self-citationMartini, A., Lovell, D. J., Albani, S., Brunner, H. I., Hyrich, K. L., Thompson, S. D., & Ruperto, N. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00332-8 · Cited by 289
Metadata
- Authors
- Saper, V. E., Chen, G., Deutsch, G. H., Guillerman, R. P., Birgmeier, J., Jagadeesh, K., Canna, S., Schulert, G., Deterding, R., Xu, J., Leung, A. N., Bouzoubaa, L., Abulaban, K., Baszis, K., Behrens, E. M., Birmingham, J., Casey, A., Cidon, M., Cron, R. Q., De, A., De Benedetti, F., Ferguson, I., Fishman, M. P., Goodman, S. I., Graham, T. B., Grom, A. A., Haines, K., Hazen, M., Henderson, L. A., Ho, A., Ibarra, M., Inman, C. J., Jerath, R., Khawaja, K., Kingsbury, D. J., Klein-Gitelman, M., Lai, K., Lapidus, S., Lin, C., Lin, J., Liptzin, D. R., Milojevic, D., Mombourquette, J., Onel, K., Ozen, S., Perez, M., Phillippi, K., Prahalad, S., Radhakrishna, S., Reinhardt, A., Riskalla, M., Rosenwasser, N., Roth, J., Schneider, R., Schonenberg-Meinema, D., Shenoi, S., Smith, J. A., Sönmez, H. E., Stoll, M. L., Towe, C., Vargas, S. O., Vehe, R. K., Young, L. R., Yang, J., Desai, T., Balise, R., Lu, Y., Tian, L., Bejerano, G., Davis, M. M., Khatri, P., & Mellins, E. D.
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 2019-12
- Volume
- 78
- Issue
- 12
- Pages
- 1722-1731
- ISSN
- 0003-4967 (ISSN-L)
- OpenAlex
- W2975994788
- Cited by
- 223
- References
- 4
- FWCI
- 13.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Emergent high fatality lung disease in systemic juvenile arthritis. https://app.cochat.ai/papers/10.1136/annrheumdis-2019-216040
- The paper
- Saper, V. E., Chen, G., Deutsch, G. H., Guillerman, R. P., Birgmeier, J., Jagadeesh, K., Canna, S., Schulert, G., Deterding, R., Xu, J., Leung, A. N., Bouzoubaa, L., Abulaban, K., Baszis, K., Behrens, E. M., Birmingham, J., Casey, A., Cidon, M., Cron, R. Q., . . . Mellins, E. D. (2019). Emergent high fatality lung disease in systemic juvenile arthritis. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2019-216040
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.